transition from semaglutide to tirzepatide Switching Tirzepatide: What to Expect 🥇 Switching from Semaglutide to

GLP-1 is a hormone that your small intestine makes already

Following Novo Nordisks announcement that its Wegovy injection for obesity demonstrated a 20 percent reduction in major adverse cardiovascular outcomes, the pharma giant has launched the semaglutide treatment in the UK

It's effective for both men and women

Additionally, a 2020 study including 225 adults with binge eating disorder found Noom to be more effective at reducing the number of days participants engaged in binge eating over 52 weeks compared with standard care offerings

As semaglutide gained popularity for weight loss, some patients turned to compounded versions due to perceived cost savings or unavailability of FDA-approved products

Approved for chronic weight management in adults with obesity or overweight and at least one weight-related comorbidity